Akzo Nobel posted strong Q2 earnings despite Covid-19 pandemic

Akzo Nobel, the specialty chemicals company, posted 2Q adjusted operating income slid 22% on year to 238 million euros on revenue of 1.99 billion euros, down 19%.

Trading floor 1

Akzo Nobel, the specialty chemicals company, posted 2Q adjusted operating income slid 22% on year to 238 million euros on revenue of 1.99 billion euros, down 19%. The company said: "Market headwinds continued to ease during Q2, although revenue for June was nearly 5% lower than the same month in 2019."

From a chartist point of view, the stock price remains within a short term bullish trend but is now approaching from the resistance threshold at 84.3E (gap) and the upper Bollinger band on a weekly chart. Investors have to remain cautious as these levels may trigger profit taking. Keep a close eye on the key support at 72.3E. Prices need to stand above this support level to maintain the bullish bias. A push above 86E would open a path to see the key long term horizontal resistance threshold at 94E.

Source: GAIN Capital, TradingView


More from Equities

Disclaimer: GAIN Capital UK Limited (trading as "Forex.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, Forex.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by Forex.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although Forex.com is not specifically prevented from dealing before providing this material, Forex.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.